Asset Dedication LLC held its stake in Anthem, Inc. (NYSE:ANTM) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 959 shares of the company’s stock at the end of the second quarter. Asset Dedication LLC’s holdings in Anthem were worth $179,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. raised its position in shares of Anthem by 2,873.5% in the first quarter. BlackRock Inc. now owns 22,676,945 shares of the company’s stock valued at $3,750,316,000 after buying an additional 21,914,321 shares during the period. Dodge & Cox purchased a new position in shares of Anthem during the fourth quarter valued at approximately $432,031,000. Boston Partners raised its position in shares of Anthem by 112.6% in the first quarter. Boston Partners now owns 3,895,863 shares of the company’s stock valued at $644,298,000 after buying an additional 2,063,562 shares during the period. Wellington Management Group LLP raised its position in shares of Anthem by 53.5% in the first quarter. Wellington Management Group LLP now owns 4,443,160 shares of the company’s stock valued at $734,810,000 after buying an additional 1,548,077 shares during the period. Finally, OZ Management LP purchased a new position in shares of Anthem during the first quarter valued at approximately $192,493,000. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Anthem, Inc. (NYSE ANTM) traded down 0.15% during midday trading on Friday, hitting $189.43. The stock had a trading volume of 1,212,413 shares. The company’s 50 day moving average is $189.83 and its 200 day moving average is $176.05. Anthem, Inc. has a 52-week low of $114.85 and a 52-week high of $194.94. The company has a market cap of $49.74 billion, a PE ratio of 17.91 and a beta of 0.73.
Anthem (NYSE:ANTM) last released its earnings results on Wednesday, July 26th. The company reported $3.37 EPS for the quarter, beating analysts’ consensus estimates of $3.23 by $0.14. The firm had revenue of $22.20 billion for the quarter, compared to analysts’ expectations of $22.25 billion. Anthem had a return on equity of 12.93% and a net margin of 3.24%. The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.33 earnings per share. On average, analysts anticipate that Anthem, Inc. will post $11.82 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.70 per share. This is a boost from Anthem’s previous quarterly dividend of $0.65. The ex-dividend date is Thursday, September 7th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.48%. Anthem’s dividend payout ratio is currently 24.62%.
ILLEGAL ACTIVITY NOTICE: “Asset Dedication LLC Has $179,000 Position in Anthem, Inc. (ANTM)” was first posted by BNB Daily and is the sole property of of BNB Daily. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.baseball-news-blog.com/2017/08/13/asset-dedication-llc-maintains-position-in-anthem-inc-antm-updated-updated-updated.html.
Several equities analysts have recently commented on ANTM shares. Deutsche Bank AG increased their price objective on Anthem from $166.00 to $173.00 and gave the company a “hold” rating in a research report on Friday, April 28th. Sanford C. Bernstein increased their price objective on Anthem from $202.00 to $212.00 and gave the company an “outperform” rating in a research report on Friday, April 28th. Cantor Fitzgerald upgraded Anthem from a “hold” rating to an “overweight” rating and increased their price objective for the company from $165.00 to $210.00 in a research report on Thursday, April 27th. Citigroup Inc. reiterated a “buy” rating and set a $205.00 price objective on shares of Anthem in a research report on Wednesday, June 28th. Finally, Credit Suisse Group started coverage on Anthem in a research report on Wednesday, July 12th. They set a “neutral” rating and a $195.00 price objective on the stock. Twelve equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $180.00.
In related news, EVP Thomas C. Zielinski sold 9,127 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $191.25, for a total value of $1,745,538.75. Following the transaction, the executive vice president now owns 26,571 shares of the company’s stock, valued at $5,081,703.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Julie A. Hill sold 524 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $190.80, for a total value of $99,979.20. Following the completion of the transaction, the director now directly owns 36,924 shares in the company, valued at approximately $7,045,099.20. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,754 shares of company stock worth $2,595,073. Insiders own 0.36% of the company’s stock.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.